Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Latest filing published 14 Sept 2026 for Amylyx Pharmaceuticals, Inc., €266k. Read the official filing
Filing timeline
BuySaleGina Mazzariello
Insider track record
Disclosed buys
0
Disclosed sells
19
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Gina Mazzariello: trading record in brief
All filings by Gina Mazzariello on record concern Amylyx Pharmaceuticals, Inc., in the capacity of senior executive. The record holds 28 filings, for trades running from 22 February 2022 to 10 September 2026.
Every open-market trade on record is a sale: 19 sales worth €1.5M. The rest of the record consists of 7 share grants. 2026 to date brings no purchases and 7 sales.
The newest entry dates from 14 September 2026: an open-market sale of €266k, in Amylyx Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gina Mazzariello
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
9,525 shares@ US$32.4556Common StockSEC:0001193125-26-390508:0
11 shares@ US$33.34Common StockSEC:0001193125-26-390508:1
21,284 shares0Common StockSEC:0001193125-26-359677:0
15,000 shares@ US$18.31640.0065% mcap19.0% of flowCommon StockSEC:0001193125-26-301996:0
15,000 shares@ US$17.60810.0063% mcap18.2% of flowCommon StockSEC:0001193125-26-301996:1
74,660 shares0Common StockSEC:0001193125-26-098439:0
6,844 shares@ US$14.520510.6% of flowCommon StockSEC:0001193125-26-091436:0
3,419 shares@ US$14.14225.1% of flowCommon StockSEC:0001193125-26-071460:0
3,448 shares@ US$14.65075.4% of flowCommon StockSEC:0001193125-26-037548:0
8,828 shares@ US$14.575117.5% of flowCommon StockSEC:0001193125-25-228342:0
15,000 shares@ US$8.073520.1% of flowCommon StockSEC:0000950170-25-108912:0
1,000 shares0Common StockSEC:0000950170-25-077677:0
9,192 shares@ US$3.47637.2% of flowCommon StockSEC:0000950170-25-049560:0
63,851 shares0Common StockSEC:0000950170-25-036717:0
1,611 shares@ US$3.11751.2% of flowCommon StockSEC:0000950170-25-033717:0
4,169 shares@ US$3.1533.0% of flowCommon StockSEC:0000950170-25-027833:0
3,678 shares@ US$3.49083.0% of flowCommon StockSEC:0000950170-25-014620:0
8,709 shares@ US$3.19676.1% of flowCommon StockSEC:0000950170-24-111805:0
10,455 shares@ US$1.87994.4% of flowCommon StockSEC:0000950170-24-061293:0
80,560 shares0Common StockSEC:0000950170-24-045695:0
1,540 shares@ US$18.72796.4% of flowCommon StockSEC:0000950170-24-027921:0
36,667 shares0Common StockSEC:0000950170-24-022400:0
2,838 shares@ US$18.756411.9% of flowCommon StockSEC:0000950170-24-021472:0
6,164 shares@ US$20.877128.6% of flowCommon StockSEC:0000950170-23-043242:0
500 shares0Common StockSEC:0000950170-23-023240:0
25 of 28 declarations
